In a review of 947 participants in a larger study about the efficacy of the COVID-19 vaccines, researchers found that “opposite-arm” patients had better results than the “same-arm” group. When the first and second COVID-19 vaccines were administered in different arms, antibody titers were 1.2-fold higher at week two, 1.4-fold higher at week three and 1.4-fold higher at week four.
“It is commonly expected that immune responses are indifferent to ipsilateral [same arm] versus contralateral [opposite arm] boosting as part of a multi-dose intramuscular vaccine regimen,” the researchers wrote in The Journal of Clinical Investigation. But, the new findings indicate switching up injection sites can improve patient outcomes.
In conclusion, they said further research is needed, especially among younger populations, since immune responses might differ in children.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
